The detrimental effects of stress on human health are being increasingly recognized. There
is a critical need for the establishment of a biomarker that accurately measures its intensity …

Before marketing a new drug, the manufacturer almost never tests the product in pregnant
women to determine its effects on the fetus. Consequently, most drugs are not labeled for use …

Background Many women of reproductive age have depression, necessitating therapy with
either a tricyclic antidepressant drug or a drug, such as fluoxetine, that inhibits the reuptake …

In April, 2005, a full-term healthy male infant, delivered vaginally, showed intermittent periods
of difficulty in breastfeeding and lethargy starting on day 7. During a well-baby paediatric …

OBJECTIVE: Current estimates of the prevalence of depression during pregnancy vary widely.
A more precise estimate is required to identify the level of disease burden and develop …

Background Preliminary studies suggested that pain experienced by infants in the neonatal
period may have long-lasting effects on future infant behaviour. The objectives of this study …

Background The prognosis of patients with homozygous β-thalassemia (thalassemia major)
has been improved by transfusion and iron-chelation therapy. We analyzed outcome and …

Background: Corticosteroids are first-line drugs for the treatment of a variety of conditions in
women of childbearing age. Information regarding human pregnancy outcome with …

Objective: Depression often remains undertreated during pregnancy and there is growing
evidence that untoward perinatal outcomes can result. Our systematic review and meta-…

Objective This executive summary presents in brief the current evidence assessed in the
clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy …